Myriad Genetics Inc/ US62855J1043 /
| 2024-04-23 10:00:00 PM | Chg. +0.1100 | Volume | Bid11:32:56 PM | Ask11:32:56 PM | High | Low |
|---|---|---|---|---|---|---|
| 18.6000USD | +0.59% | 508,160 Turnover: 6.54 mill. |
17.6000Bid Size: 100 | 19.3600Ask Size: 100 | 19.0000 | 18.5100 |
GlobeNewswire
04-17
Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According t...
GlobeNewswire
04-16
New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 2...
GlobeNewswire
04-09
Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after Gene...
GlobeNewswire
04-05
Leash Biosciences Announces $9.3 Million Seed Financing to Pioneer AI-Driven Medicinal Chemistry
GlobeNewswire
03-22
Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Earl...
GlobeNewswire
03-13
BioHive to launch HealthTech Hub Chapter to Empower Medical Innovation and Disrupt Healthcare
GlobeNewswire
02-27
Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Result...
GlobeNewswire
02-27
Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter R...
GlobeNewswire
02-27
Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Moni...
GlobeNewswire
02-21
Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
GlobeNewswire
02-15
Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s Healt...
GlobeNewswire
02-01
Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermoun...
GlobeNewswire
01-30
Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology
GlobeNewswire
01-19
Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision...
GlobeNewswire
01-09
Myriad Genetics Applauds New Germline Testing Guideline for Patients with Breast Cancer from ASCO-SS...
GlobeNewswire
2023-12-21
Myriad Genetics Chief Financial Officer Bryan Riggsbee Retires; Scott Leffler Appointed as Successor...
GlobeNewswire
2023-12-20
Myriad Genetics Establishes Comprehensive Pan-Cancer Research Platform to Advance Patient Care
GlobeNewswire
2023-11-20
Myriad Genetics Celebrates One Million SneakPeek® Results Shared with Expectant Parents
GlobeNewswire
2023-11-16
Myriad Genetics and Personalis Partner to Market Solutions to Pharma Customers
GlobeNewswire
2023-11-08
Myriad Genetics Announces Proposed Offering of $100 Million of Shares of Common Stock
